North America Genetic Testing Services Market to 2027 - Regional Analysis and Forecasts by Type (Predictive Testing, Carrier Testing, Prenatal Testing, New-born Screening and Others), Disease (Cancer Disease, Metabolic Diseases, Cardiovascular Diseases and Others), Service Provider (Diagnostic Laboratories, Hospital-Based Laboratories and Clinics) and Country
The North America genetic testing services market is expected to reach US$ 7,406.0 Mn in 2027 from US$ 3,044.4 Mn in 2019. The market is estimated to grow with a CAGR of 12.1% from 2020-2027.
The growth of the market is driven by factors such as rising prevalence of the genetic diseases and rise in awareness & acceptance of personalized medicines. Also, growing preference towards Direct-To-Consumer (DTC) genetic testing, support of government to adopt genetic testing services is positively impacting the growth of the market in the review period. In addition, various strategic initiatives by the manufacturers, new product launch along with artificial intelligence (AI) powered genetic testing is likely to boost the growth of market.
The demand for the market in the region is anticipated to witness growth at a significant rate during the forecast period owing to various factors such as, rising cancer patients, increasing government funding among others. The rising incidence of genetic diseases among the population in US and Canada during recent years has fuelled the demand for genetic testing market in the region during the forecast period.
Moreover, increasing focus on advanced method incorporation in healthcare, government and private initiatives for promotion of precision medicine and massive funds from government and private bodies for genetic research is further expected stimulate the growth and contribute to exceptional revenue generation for the genetic testing market in North America.
Furthermore, the demand for genetic testing in the United States has been expected to witness growth, since the service encompasses a broad range of applications such as, cancer, autoimmune diseases and infectious diseases. In US, the products for genetic testing of pediatric as well as rare diseases has increased significantly. As per the estimates of National Institutes of Health (NIH), in the United States, there are around 25 to 30 million people suffering from rare diseases, accounting for individuals fewer than 200,000 people. Rare diseases are often the result of a genetic mutation; one estimate is that 80% of rare diseases are genetic in nature. Also, 50% of patients with rare diseases are children.
Moreover, in recent days there have been various activities that have led to the growth of the genetic testing services market in Mexico. For instance, in June 2017, Pathway Genomics and Salud Interactiva entered a partnership to bring advanced clinical genetic testing to millions in Mexico. Also, during June, 2017, pharmacogenomics leader OneOme entered a partnership with Mexico City-based Total Quality Medicine (TQM). Through the agreement, OneOme’s pharmacogenomic (PGx) testing and support services would be offered to patients in Mexico, as TQM integrates OneOme’s RightMed PGx test into its GeneTest line of personalized medicine products. Due to the above stated factors, the market for genetic testing in Mexico is anticipated to witness significant growth during the forecast period.
Mexico Genetic testing services market Revenue and Forecasts to 2027 (US$ Mn)
Get more information on this report :
NORTH AMERICA GENETIC TESTING SERVICES – MARKET SEGMENTATION
By Type
- Predictive Testing
- Carrier Testing
- Prenatal Testing
- New-born Screening
- Others
NORTH AMERICA GENETIC TESTING SERVICES – MARKET SEGMENTATION
By Disease
- Cancer
- Metabolic Diseases
- Cardiovascular Diseases
- Others
NORTH AMERICA GENETIC TESTING SERVICES – MARKET SEGMENTATION
By Service Provider
- Cancer
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Clinics
By Country
- US
- Mexico
- Canada
Companies Mentioned
- Thermo Fischer Scientific Inc.
- Laboratory Corporation of America Holdings
- F. Hoffmann-La Roche Ltd.
- Illumina, Inc.
- Quest Diagnostics Incorporated
- Exact Sciences Corporation
- NeoGenomics Laboratories, Inc.
- Eurofins Scientific
- Ambry Genetics
- Centogene AG
- 23andMe, Inc.
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. North America Genetic Testing Services Market – Key Takeaways
3. North America Genetic Testing Services Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 North America Genetic Testing Services Market – By Type
3.2.2 North America Genetic Testing Services Market – By Disease
3.2.3 North America Genetic Testing Services Market – By Service Provider
3.2.4 North America Genetic Testing Services Market – By Country
3.3 PEST Analysis
3.4 Expert Opinions
4. North America Genetic Testing Services Market-Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rising Prevalence of Genetic Diseases in North America
4.1.2 Rise in Awareness & Acceptance of Personalized Medicines
4.2 Key Market Restraints
4.3 Social and Ethical Implications of Genetic Testing
4.4 Key Market Opportunities
4.4.1 Growing Preference towards Direct-To-Consumer (DTC) Genetic Testing in North America
4.5 Future Trends
4.5.1 Artificial Intelligence (AI) Powered Genetic Testing
4.6 Impact Analysis Of Drivers And Restraints
5. Genetic Testing Services Market – North America Analysis
5.1 North America Genetic Testing Services Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players
5.3.1 Thermo Fischer Scientific Inc.,
5.3.2 F. Hoffmann-La Roche Ltd
5.3.3 Illumina, Inc.
6. North America Genetic Testing Services Market Analysis – By Type
6.1 Overview
6.2 North America Genetic Testing Services Market, By Type, 2019 & 2027 (%)
6.3 North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Type (Us$ Mn)
6.4 New-born Screening Market
6.4.1 Overview
6.4.2 New-born Screening Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Prenatal Testing Market
6.5.1 Overview
6.5.2 Prenatal Testing Market Revenue and Forecast to 2027 (US$ Mn)
6.6 Predictive Testing Market
6.6.1 Overview
6.6.2 Predictive Testing Market Revenue and Forecast to 2027 (US$ Mn)
6.7 Carrier Testing Market
6.7.1 Overview
6.7.2 Carrier Testing Market Revenue and Forecast to 2027 (US$ Mn)
6.8 Other Testing’s Market
6.8.1 Overview
6.8.2 Other Testing’s Market Revenue and Forecast to 2027 (US$ Mn)
7. North America Genetic Testing Services Market Analysis – By Disease
7.1 Overview
7.2 North America Genetic Testing Services Market, By Disease, 2019 & 2027 (%)
7.3 North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Disease (Us$ Mn)
7.4 Cancer Market
7.4.1 Overview
7.4.2 Cancer Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Metabolic Diseases Market
7.5.1 Overview
7.5.2 Metabolic Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Cardiovascular Disease Market
7.6.1 Overview
7.6.2 Cardiovascular Disease Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Other Diseases Market
7.7.1 Overview
7.7.2 Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Genetic Testing Services Market Analysis – By Service Provider
8.1 Overview
8.2 North America Genetic Testing Services Market, By Service Provider, 2019 & 2027 (%)
8.3 North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Disease (Us$ Mn)
8.4 Diagnostic Laboratories Market
8.4.1 Overview
8.4.2 Diagnostic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Hospital-Based Laboratories Market
8.5.1 Overview
8.5.2 Hospital-Based Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Clinics Market
8.6.1 Overview
8.6.2 Clinics Market Revenue and Forecast to 2027 (US$ Mn)
9. North America Genetic Testing Services Market Revenue And Forecasts To 2027
9.1 Overview
9.2 North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Country (%)
9.2.1 US Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.2 US Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.2.1 US Genetic Testing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.2.2 US Genetic Testing Services Market Revenue And Forecasts to 2027, By Disease (US$ Mn)
9.2.2.3 US Genetic Testing Services Market, Revenue and Forecast to 2027, by Service Provider (US$ Mn)
9.2.3 Canada Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.4 Canada Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.4.1 Canada Genetic Testing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.4.2 Canada Genetic Testing Services Market Revenue And Forecasts to 2027, By Disease (US$ Mn)
9.2.4.3 Canada Genetic Testing Services Market Revenue And Forecasts to 2027, By Service Provider (US$ Mn)
9.2.5 Mexico Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6 Mexico Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.1 Mexico Genetic Testing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.6.2 Mexico Genetic Testing Services Market Revenue And Forecasts to 2027, By Disease (US$ Mn)
9.2.6.3 Mexico Genetic Testing Services Market Revenue And Forecasts to 2027, By Service Provider (US$ Mn)
10. Genetic Testing Services Market –Industry Landscape
10.1 Overview
10.2 Growth Strategies In The Genetic Testing Services Market, 2017-2020
10.3 Organic Developments
10.3.1 Overview
10.3.2 Organic Growth Strategies In The Genetic Testing Services Market, 2017-2020
10.4 Inorganic Developments
10.4.1 Overview
10.4.2 Inorganic Growth Strategies In The Genetic Testing Services Market, 2017-2020
11. Genetic Testing Services Market- Key Company Profiles
11.1 Laboratory Corporation of America Holdings
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 F. HOFFMANN-LA ROCHE LTD
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Illumina, Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Quest Diagnostics Incorporated
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Exact Sciences Corporation
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 NeoGenomics Laboratories, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Eurofins Scientific
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Ambry Genetics
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Centogene AG
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10andMe, Inc.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 THERMO FISHER SCIENTIFIC INC.
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Products and Services
11.11.4 Financial Overview
11.11.5 SWOT Analysis
11.11.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary Of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
Table 1. North America Genetic Testing Services market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 2. North America Genetic Testing Services market Revenue And Forecasts to 2027, By Disease (US$ Mn)
Table 3. North America Genetic Testing Services market Revenue And Forecasts to 2027, By disease (US$ Mn)
Table 4. US Genetic Testing Services market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 5. US Genetic Testing Services market Revenue And Forecasts to 2027, By Disease (US$ Mn)
Table 6. US Genetic Testing Services Market, Revenue and Forecast To 2027, by Service Provider (US$ Mn)
Table 7. Canada Genetic Testing Services market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 8. Canada Genetic Testing Services market Revenue And Forecasts to 2027, By Disease (US$ Mn)
Table 9. Canada Genetic Testing Services market Revenue And Forecasts to 2027, By Service Provider (US$ Mn)
Table 10. Mexico Genetic Testing Services market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 11. Mexico Genetic Testing Services market Revenue And Forecasts to 2027, By Disease (US$ Mn)
Table 12. Mexico Genetic Testing Services market Revenue And Forecasts to 2027, By Service Provider (US$ Mn)
Table 13. Recent Organic Growth Strategies In The Genetic Testing Services Market
Table 14. Recent Inorganic Growth Strategies In The Genetic Testing Services Market
Table 15. Glossary of Terms, Genetic Testing Services market
LIST OF FIGURES
Figure 1. US Genetic Testing Services Market, Revenue (US$ Mn), By 2019 & 2027
Figure 2. North America Genetic Testing Services Market By Type , Market Share (%), 2019
Figure 3. North America Genetic Testing Services Market By Disease, Market Share (%), 2019
Figure 4. North America Genetic Testing Services Market By Service Provider, Market Share (%), 2019
Figure 5. Genetic Testing Services Market Segmentation
Figure 6. North America PEST Analysis
Figure 7. Genetic Testing Services Market Impact Analysis Of Driver And Restraint
Figure 8. North America Genetic Testing Services Market – Revenue Forecasts And Analysis – 2019- 2027
Figure 9. North America Genetic Testing Services Market By Type, 2019 & 2027 (%)
Figure 10. New-born Screening Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 11. Prenatal Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 12. Predictive Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 13. Carrier Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 14. Other Testing’s Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 15. North America Genetic Testing Services Market By Disease, 2019 & 2027 (%)
Figure 16. Cancer Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 17. Metabolic Disease Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 18. Cardiovascular Disease Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. Other Diseases Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 20. North America Genetic Testing Services Market By Service Provider, 2019 & 2027 (%)
Figure 21. Diagnostic Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 22. Hospital-Based Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 23. Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 24. North America Genetic Testing Services Market REVENUE, By Country, 2019 (US$ MN)
Figure 25. North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Country (%)
Figure 26. US Genetic Testing Services Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 27. Canada Genetic Testing Services Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 28. Mexico Genetic Testing Services Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 29. Growth Strategies In The Genetic Testing Services Market, 2017-2020
The List of Companies - North America Genetic Testing Services Market
- Thermo Fischer Scientific Inc.
- Laboratory Corporation of America Holdings
- F. Hoffmann-La Roche Ltd.
- Illumina, Inc.
- Quest Diagnostics Incorporated
- Exact Sciences Corporation
- NeoGenomics Laboratories, Inc.
- Eurofins Scientific
- Ambry Genetics
- Centogene AG
- 23andMe, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the genetic testing services market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America genetic testing services market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.